Lynda Wyld Selected Research

Drug Therapy (Chemotherapy)

1/2022	The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: National practice questionnaire of United Kingdom multi-disciplinary decision making.
1/2021	Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer.
1/2021	Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer.
1/2019	The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
1/2018	Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
7/2017	Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial.
1/2017	GENE EXPRESSION PROFILING AND EXPANDED IMMUNOHISTOCHEMISTRY TESTS TO GUIDE SELECTION OF CHEMOTHERAPY REGIMENS IN BREAST CANCER MANAGEMENT: A SYSTEMATIC REVIEW.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lynda Wyld Research Topics

Disease

19	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2007
3	Neoplasms (Cancer) 01/2021 - 12/2015
2	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 01/2021
2	Nausea 01/2021 - 05/2014
2	Fatigue 01/2021 - 01/2021
1	Triple Negative Breast Neoplasms 01/2022
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2021
1	Vomiting 01/2021
1	Constipation 01/2021
1	Dyspareunia 01/2019
1	Unilateral Breast Neoplasms 01/2018
1	Liposarcoma 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Genomic Instability 01/2018
1	Frailty 07/2017
1	Headache (Headaches) 05/2014
1	Exanthema (Rash) 05/2014
1	Alopecia (Baldness) 05/2014
1	Thrombophlebitis 05/2014
1	Vertigo (Positional Vertigo) 05/2014
1	Cystitis 05/2014
1	Sleepiness 05/2014
1	Vaginal Discharge 05/2014
1	Mastodynia 05/2014
1	Pruritus (Itching) 05/2014
1	Dyspepsia (Indigestion) 05/2014
1	Philadelphia Chromosome 03/2011
1	Intra-Abdominal Hypertension 03/2011
1	Respiratory Acidosis 03/2011

Drug/Important Bio-Agent (IBA)

2	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2018
2	Tamoxifen FDA LinkGeneric 05/2014 - 04/2008
1	fisetinIBA 07/2020
1	navitoclaxIBA 07/2020
1	QuercetinIBA 07/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	pertuzumabIBA 01/2018
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	N-hydroxysuccinimide suberic acid ester (DSIS)IBA 06/2015
1	GasesIBA 03/2011
1	Imatinib Mesylate (Gleevec)FDA Link 03/2011

Therapy/Procedure

10	Therapeutics 01/2021 - 10/2007
8	Animal Assisted Therapy 01/2021 - 04/2008
7	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
2	Salpingo-oophorectomy 10/2021 - 01/2021
1	Transjugular Intrahepatic Portasystemic Shunt 01/2021
1	Radiotherapy 01/2021
1	Lasers (Laser) 01/2019
1	Mastectomy (Mammectomy) 01/2018
1	Neoadjuvant Therapy 01/2018
1	Adjuvant Chemotherapy 01/2017
1	Activities of Daily Living (ADL) 12/2015
1	Splenectomy 03/2011
1	Laparotomy 03/2011